Matthew Gline
2021
In 2021, Matthew Gline earned a total compensation of $30.5M as Principal Executive Officer at Roivant Sciences Ltd., a 267% increase compared to previous year.
Compensation breakdown
| Bonus | $710,500 |
|---|---|
| Option Awards | $19,513,106 |
| Salary | $725,000 |
| Stock Awards | $9,500,630 |
| Other | $10,795 |
| Total | $30,460,032 |
Gline received $19.5M in option awards, accounting for 64% of the total pay in 2021.
Gline also received $710.5K in bonus, $725K in salary, $9.5M in stock awards and $10.8K in other compensation.
Rankings
In 2021, Matthew Gline's compensation ranked 148th out of 12,415 executives tracked by ExecPay. In other words, Gline earned more than 98.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 148 out of 12,415 | 99th |
Division Manufacturing | 40 out of 5,505 | 99th |
Major group Chemicals And Allied Products | 15 out of 2,375 | 99th |
Industry group Drugs | 11 out of 2,096 | 100th |
Industry Pharmaceutical Preparations | 4 out of 1,546 | 100th |
Source: SEC filing on July 26, 2022.
Gline's colleagues
We found two more compensation records of executives who worked with Matthew Gline at Roivant Sciences Ltd. in 2021.